MedPath
TGA Approval

OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard (427223)

427223

OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard

Celltrion Healthcare Australia Pty Ltd

November 26, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/4a02a641f6e1915bcfce269fb67fa988.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/37b6bc6a49bda9137cdcff417cf7ef38.pdf

Active Ingredients

Omalizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard (427223) - TGA 批准文号 | MedPath